(COVID-19) vaccines have gained widespread use across the globe to prevent further
spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Early …

Wide availability of the 3 vaccines approved by the US Food and Drug Administration for
emergency use against SARS-CoV-2 has led to reports of adverse reactions not seen during …

Importance The BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine was
authorized on May 10, 2021, for emergency use in children aged 12 years and older. Initial …

Background Clinical trials of the BNT162b2 vaccine, revealed efficacy and safety. We report
six cases of myocarditis, which occurred shortly after BNT162b2 vaccination. Methods …

Myocarditis following mRNA COVID-19 vaccination has recently been reported to health
authorities in the United States and other countries. Cases predominately occur in young …

3. Calderó n J, Sandoval J, Beltrá n M. Hipertensió n pulmonar asociada con cardiopatıas
congé nitas y sındrome de Eisenmenger. Arch Cardiol Mex. 2015; 85: 32–49. 4. van der …

Background Reports have suggested an association between the development of
myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus …

Two reports in the current issue of JAMA Cardiology describe cases of acute myocarditis that
occurred among persons who received the BNT162b2-mRNA (Pfizer-BioNTech) or mRNA …

The global coronavirus disease 2019 (COVID-19) pandemic brought significant mortality
with more than 3 million deaths worldwide since January 2020. 1 Concerted efforts focused …

Abstract Background Approximately 5.1 million Israelis had been fully immunized against
coronavirus disease 2019 (Covid-19) after receiving two doses of the BNT162b2 messenger …